10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Macrolides are a class of antimicrobial drugs that play a crucial role in combating bacterial infections. One of their key characteristics is the presence of a macrocyclic lactone ring, which contributes to their efficacy. Commonly used macrolides include erythromycin, azithromycin, and clarithromycin. These antibiotics function by inhibiting bacterial protein synthesis. Macrolides bind to the 50S subunit of the bacterial ribosome, preventing the elongation of the nascent peptide chain. This mechanism disrupts bacterial protein synthesis, ultimately leading to bacteriostatic or bactericidal effects, depending on the concentration. Macrolides are particularly effective against respiratory tract infections, skin infections, and certain sexually transmitted diseases. Azithromycin, in particular, is known for its extended half-life and convenient dosing regimen, making it a popular choice for various infections. Despite their efficacy, macrolides are not without side effects. Gastrointestinal disturbances, such as nausea and abdominal pain, are common, and they may interact with other medications through cytochrome P450 enzymes.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : An unprecedented West Nile virus outbreak in Israel (2024): A textbook case for the One Health approach
Michel Bellaiche, Kimron Veterinary Institute, Israel
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, IDFISH Technology, United States
Title : Candida auris infections are global health challenge
Reza Nassiri, Michigan State University, United States
Title : Host brakes on viral inflammation
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States